Rate My Professor Mageswary Sivalingam

Dr. Sivalingam's research interests center on negative emotions and related psychiatric disorders, such as post-traumatic stress disorder (PTSD), depression, and associated neurodegenerative diseases, along with mental health disorders, neuroinflammation, and molecular biology. Key publications include "Chronic unpredictable stress (CUS) reduced phoenixin expression, induced abnormal sperm and testis morphology in male rats" (Neuropeptides, October 2024), "Regulation of EMT Markers, Extracellular Matrix, and Associated Signalling Pathways by Long Non-Coding RNAs in Glioblastoma Mesenchymal Transition: A Scoping Review" (Biology, June 2023), "Conserved functions of hypothalamic kisspeptin in vertebrates" (General and Comparative Endocrinology, February 2022), and "Hypothalamic kisspeptin and kisspeptin receptors: Species variation in reproduction and reproductive behaviours" (Frontiers in Neuroendocrinology, January 2022). She has received a Prize in 2021 for "A novel anti-NRP2 monoclonal antibody-based therapeutics against Chikungunya virus (CHIKV)" and an Other Distinction in 2020 for "Cross-talks between Inflammation and the gut microbiome: Implications on mental illness with the alteration of the metabolic system." Dr. Sivalingam is currently accepting PhD students, contributes to SDG 3 Good Health and Well-being, and is a member of the programme committee for "Co-design for Equitable Research in Women’s Health" scheduled for 15 July 2025.